<?xml version="1.0" encoding="UTF-8"?>
<ref id="B102-pharmaceuticals-12-00157">
 <label>102.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Munjal</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Khandia</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Dhama</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Sachan</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Karthik</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Tiwari</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Malik</surname>
    <given-names>Y.S.</given-names>
   </name>
   <name>
    <surname>Kumar</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Singh</surname>
    <given-names>R.K.</given-names>
   </name>
   <name>
    <surname>Iqbal</surname>
    <given-names>H.M.N.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Advances in Developing Therapies to Combat Zika Virus: Current Knowledge and Future Perspectives</article-title>
  <source>Front. Microbiol.</source>
  <year>2017</year>
  <volume>8</volume>
  <elocation-id>1469</elocation-id>
  <pub-id pub-id-type="doi">10.3389/fmicb.2017.01469</pub-id>
  <pub-id pub-id-type="pmid">28824594</pub-id>
 </element-citation>
</ref>
